Larvol Delta - Avenzo-Therapeutics-Advances-the-Combination-of-CDK4-Selective-Inhibitor-AVZO023-with-CDK2-Selective-Inhibitor-AVZO021-in-Ongoing-Phase-12-ORION1-Study-in-HRHER2-Breast-Cancer

AVZO-023 - Avenzo Therap

AVZO-021 - Avenzo Therap

https://www.businesswire.com/news/home/20260428503454/en/Avenzo-Therapeutics-Advances-the-Combination-of-CDK4-Selective-Inhibitor-AVZO-023-with-CDK2-Selective-Inhibitor-AVZO-021-in-Ongoing-Phase-12-ORION-1-Study-in-HRHER2--Breast-Cancer

Apr 28, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next